[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Capricor Therap (CAPR)

Capricor Therap (CAPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Capricor Therap 10865 Road to the Cure Suite 150 San Diego CA 92121 USA

www.capricor.com Employees: 231 P: 858-727-1755

Sector:

Medical

Description:

Capricor Therapeutics, Inc. is a biotechnology company. It is focused on the development of novel therapeutics to prevent and treat heart disease. The Company has two drug candidates in development: Cenderitide and CU-NP. Capricor Therapeutics, Inc., formerly known as Nile Therapeutics, Inc., is based in San Mateo, California.

Key Statistics

Overview:

Market Capitalization, $K 1,735,043
Enterprise Value, $K 1,447,193
Shares Outstanding, K 57,912
Float, K 52,584
% Float 90.80%
Short Interest, K 10,515
Short Float 18.16%
Days to Cover 12.68
Short Volume Ratio 0.66
% of Insider Shareholders 9.20%
% of Institutional Shareholders 21.68%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -105,040 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -33,940 K
EBIT, $ -119,930 K
EBITDA, $ -118,040 K

Growth:

1-Year Return 181.31%
3-Year Return 558.46%
5-Year Return 676.17%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth -156.82%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.59 on 05/12/26
Next Earnings Date 08/10/26
Earnings Per Share ttm -2.32
EPS Growth vs. Prev Qtr 4.84%
EPS Growth vs. Prev Year -11.32%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 06/05/19

CAPR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -59.27%
Return-on-Assets % -48.65%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 6.04
Book Value/Share 4.82
Interest Coverage -33.44
60-Month Beta 0.48
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.